| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Royal Jelly | Hepatic Ischemia-Reperfusion | 1 | PM | 32410568 | 📋 | The Impact of Royal Jelly against Hepatic Ischemia/Reperfusion-Induced Hepatocyte Damage in Rats: The Role of Cytoglobin, Nrf-2/HO-1/COX-4, and P38-MAPK/NF-κB-p65/TNF-α Signaling Pathways |
| Royal Jelly | Hepatitis B | 1 | PM | 36649518 | 📋 | Effect of Royal Jelly on Gene Expression of Toll-like Receptors 1-9 in Patients with Hepatitis B |
| Royal Jelly | Hepatotoxicity | 6 | PM | 38281144 | 📋 | Research progress on rat model of drug-induced liver injury established by nonsteroidal anti-inflammatory drug (celecoxib) and royal jelly ameliorative effect |
| Royal Jelly | Hepatotoxicity | 5 | PM | 36981150 | 📋 | Royal Jelly and Chlorella vulgaris Mitigate Gibberellic Acid-Induced Cytogenotoxicity and Hepatotoxicity in Rats via Modulation of the PPARĪ±/AP-1 Signaling Pathway and Suppression of Oxidative Stress and Inflammation |
| Royal Jelly | Hepatotoxicity | 4 | PM | 36416002 | 📋 | Ameliorative effects of propolis and royal jelly against CCl4-induced hepatotoxicity and nephrotoxicity in Wistar rats |
| Royal Jelly | Hepatotoxicity | 3 | PM | 36322409 | 📋 | Protective effects of royal jelly and Echinacea against moxifloxacin-induced renal and hepatic injury in rats |
| Royal Jelly | Hepatotoxicity | 2 | PM | 35303036 | 📋 | Protective potential of royal jelly against hydroxyurea -induced hepatic injury in rats via antioxidant, anti-inflammatory, and anti-apoptosis properties |
| Royal Jelly | Hepatotoxicity | 1 | PM | 35280838 | 📋 | Royal jelly protects dichlorvos liver-induced injury in male Wistar rats |
| Royal Jelly | Liver Cancer | 2 | PM | 37453194 | 📋 | Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites |
| Royal Jelly | Liver Cancer | 1 | PM | 34397053 | 📋 | Selenium-rich royal jelly inhibits hepatocellular carcinoma through PI3K/AKT and VEGF pathways in H22 tumor-bearing mice |
| Royal Jelly | MAFLD | 4 | PM | 37299544 | 📋 | Effects of Royal Jelly on Gut Dysbiosis and NAFLD in db/ db Mice |
| Royal Jelly | MAFLD | 3 | PM | 36986201 | 📋 | Activation of AMPK Entails the Protective Effect of Royal Jelly against High-Fat-Diet-Induced Hyperglycemia, Hyperlipidemia, and Non-Alcoholic Fatty Liver Disease in Rats |
| Royal Jelly | MAFLD | 1 | PM | 35510379 | 📋 | Major royal jelly proteins alleviate non-alcoholic fatty liver disease in mice model by regulating disordered metabolic pathways |
| Royal Jelly | MAFLD | 2 | PM | 33580500 | 📋 | Major royal jelly proteins prevents NAFLD by improving mitochondrial function and lipid accumulation through activating the AMPK / SIRT3 pathway in vitro |
